Integra LifeSciences
(NASDAQ) IART
Integra LifeSciences Financials at a Glance
Market Cap
$1.38B
Revenue (TTM)
$1.64B
Net Income (TTM)
-$495.80M
EPS (TTM)
-$6.46
P/E Ratio
-2.74
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Price
$17.22
Volume
31,544
Open
$17.71
Price
$17.22
Volume
31,544
Open
$17.71
Previous Close
$17.22
Daily Range
$17.08 - $17.76
52-Week Range
$8.70 - $18.19
Estimated Earnings Date
Jul 30, 2026
Dividend
$0.00
Beta (Volatility)
1.10 (Average)
Price
$17.22
Volume
31,544
Open
$17.71
Previous Close
$17.22
Daily Range
$17.08 - $17.76
52-Week Range
$8.70 - $18.19
Estimated Earnings Date
Jul 30, 2026
IART News
Integra Beats on the Bottom Line
IART: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Integra LifeSciences
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
4,427
CEO
Mojdeh Poul, MBA
Website
www.integralife.comHeadquarters
Princeton, NJ 08540, US
IART Financials
Key Financial Metrics (TTM)
Gross Margin
53%
Operating Margin
8%
Net Income Margin
-30%
Return on Equity
-39%
Return on Capital
4%
Return on Assets
-14%
Earnings Yield
-36.50%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.38B
Shares Outstanding
77.80M
Volume
31.54K
Avg. Volume
959.62K
Financials (TTM)
Gross Profit
$845.23M
Operating Income
$68.32M
EBITDA
-$326.20M
Operating Cash Flow
$50.38M
Capital Expenditure
-$95.64M
Free Cash Flow
-$45.25M
Cash & ST Invst.
$263.74M
Total Debt
$2.03B
Integra LifeSciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$391.92M
+2.4%
Gross Profit
$224.24M
+15.3%
Gross Margin
57.22%
N/A
Market Cap
$1.38B
N/A
Market Cap/Employee
$313.42K
N/A
Employees
4,396
N/A
Net Income
-$4.62M
+81.7%
EBITDA
$62.87M
+142.1%
Quarterly Fundamentals
Total Cash
$265.50M
-2.9%
Total Debt
$2.04B
+1.0%
Accounts Receivable
$264.41M
+4.7%
Inventory
$495.04M
+11.1%
Long Term Debt
$1.99B
+42.7%
Short Term Debt
$52.68M
-91.6%
Return on Assets
-13.86%
N/A
Return on Invested Capital
3.83%
N/A
Free Cash Flow
-$5.05M
+87.4%
Operating Cash Flow
$9.80M
+187.1%